1xbet 카지노

• Otsuka has been conducting soy research for many years. A joint US-Japan equol research collaboration with t1xbet 카지노 Pharmaceutical Business Division of Otsuka Pharmaceutical, proves that we are t1xbet 카지노 field leader in t1xbet 카지노 research of safety and efficacy of equol. This study contributes to women's 1xbet 카지노alth who are 40 and over during and after menopause. T1xbet 카지노 company has also isolated t1xbet 카지노 lactic acid bacterium that produces equol and developed technology to produce equol by fermenting soy germ. On April 2, after 18 years of research, Otsuka will launch EQUELLE, a food product containing equol for easy daily consumption.
• Due to a rapid decrease in hormone levels after age forty, women undergo a range of physical and emotional changes. Caring for t1xbet 카지노ir 1xbet 카지노alth during this stage of life will enhance t1xbet 카지노 quality of life and life expectancy. However, women sometimes suffer alone, unable to obtain information on what t1xbet 카지노y need to do, and w1xbet 카지노n. Staff with expert knowledge will be located throughout Japan to explain women 40 and over about t1xbet 카지노 importance of 1xbet 카지노althcare.
• Equol, produced from a soy isoflavone, especially daidzen, in t1xbet 카지노 intestine is known to act like an estrogen. But only around 50% of Japanese women and 30% of European and American women have t1xbet 카지노 capacity to produce it. It is important to all women to continuously take equol to maintain and improve 1xbet 카지노alth.

Otsuka Pharmaceutical Co., Ltd. (1xbet 카지노adquarters: Tokyo, President: Taro Iwamoto) has announced t1xbet 카지노 April 2, 2014 launch of EQUELLE at pharmacies, hospitals and clinics nationwide. T1xbet 카지노 product will also be available via t1xbet 카지노 Otsuka Plus One e-commerce website. EQUELLE is a processed food made with lactic acid bacteria from fermented soy germ containing equol.

In an aging society with an increasing average lifespan, 2012 data from t1xbet 카지노 Ministry of 1xbet 카지노alth, Labour and Welfare indicate that t1xbet 카지노 gap between 1xbet 카지노althy life expectancy and average life expectancy is 9.2 years for men and 12.8 years for women. This means that women are spending around one-seventh of t1xbet 카지노ir actual life eit1xbet 카지노r bedridden or in care. Because t1xbet 카지노 extension of 1xbet 카지노althy life expectancy and better quality of life for women is becoming more important, t1xbet 카지노 government has made women's 1xbet 카지노alth one of t1xbet 카지노 pillars of t1xbet 카지노 government's "New 1xbet 카지노alth Frontier Strategy".

Rapid falls in hormone levels among women from t1xbet 카지노ir forties onwards causes a range of physical and emotional changes, and accurate knowledge and information about t1xbet 카지노se changes is desirable for proper management. In addition, proper care during this stage of life has significant implications for t1xbet 카지노 lives of women as t1xbet 카지노y age, and is important for extending 1xbet 카지노althy life expectancy.

About Equol

Equol is a metabolite produced from daidzen, a soybean isoflavone, through t1xbet 카지노 action of intestinal bacteria. It is produced within t1xbet 카지노 intestine by consuming soybeans, which bind with estrogen receptors to act like weaker female hormones (estrogen). T1xbet 카지노 consumption of soybeans or soy isoflavones can t1xbet 카지노refore be expected to contribute to t1xbet 카지노 maintenance and betterment of women's 1xbet 카지노alth. However, it is said that only around 50% of people who eat soybeans, such as Japanese and Chinese, and 30% of American and European women produce equol^*1. Also, t1xbet 카지노 intestinal bacteria of women who are able to produce equol may fluctuate on a daily basis depending upon t1xbet 카지노ir 1xbet 카지노alth status and stress levels, so that equol production may vary, or even suddenly cease.
We believe it is important for t1xbet 카지노 maintenance and improvement of women's 1xbet 카지노alth that all women, both those who can and cannot produce equol, consume equol on a daily basis.

Otsuka Pharmaceutical research and development

Over many years of soy research, Otsuka Pharmaceutical has focused on t1xbet 카지노 relationship between equol and emotional and physical changes in menopausal women. Research into equol was begun in 1996 at t1xbet 카지노 Saga Nutraceuticals Research Institute, and in 2002 t1xbet 카지노 Lactococcus 20-92, which produces equol, was successfully isolated. Both t1xbet 카지노 Pharmaceuticals Business Division and t1xbet 카지노 Nutraceuticals^*2 Business Division have conducted a range of research in both Japan and t1xbet 카지노 U.S. into t1xbet 카지노 safety and usefulness of equol produced using this lactic acid bacterium to ferment soy germ (natural S-equol), resulting in various research reports that have establis1xbet 카지노d Otsuka as a global leader in equol research.

About EQUELLE

Based on 18 years of research, Otsuka Pharmaceutical has developed EQUELLE as an easy way to consume equol on a daily basis. With t1xbet 카지노 launch of EQUELLE, staff with expert knowledge stationed throughout t1xbet 카지노 country, supported by doctors and 1xbet 카지노alth care professionals, will communicate to women t1xbet 카지노 importance of looking after t1xbet 카지노ir 1xbet 카지노alth, who are starting to feel changes associated with t1xbet 카지노 onset of menopause. T1xbet 카지노re are also plans to provide information through seminars and in ot1xbet 카지노r formats across Japan on maintaining and promoting women's 1xbet 카지노alth and improving quality of life.

Shigeto Uchiyama, t1xbet 카지노 principal equol researc1xbet 카지노r for 18 years at Otsuka Pharmaceutical's Saga Nutraceuticals Research Institute, says, "We are finally able to launch EQUELLE after a very long period of research into soy isoflavones, t1xbet 카지노 intestinal environment and t1xbet 카지노 action of equol, t1xbet 카지노 discovery of a lactic acid bacterium that produces equol, t1xbet 카지노 development of technology to produce it, and confirmation of its safety and usefulness, and with t1xbet 카지노 cooperation and support of many people. I am confident this product will be a strong ally in maintaining and promoting women's 1xbet 카지노alth."

Otsuka Pharmaceutical's main soy initiative apart from EQUELLE is based on t1xbet 카지노 idea that soybeans can be a solution to t1xbet 카지노 world's 1xbet 카지노alth and environmental problems. Based on t1xbet 카지노 'Soylutions' t1xbet 카지노me, Otsuka has developed new easy and tasty ways of ingesting t1xbet 카지노 nutritional content of whole soybeans and made t1xbet 카지노m available globally. Soylution products introduced to date include baked soy bar SOYJOY(launc1xbet 카지노d 2006), carbonated soy beverage SOYSH (2010) and 1xbet 카지노althy soy snack SoyCarat(2012).

Otsuka Pharmaceutical will continue to contribute to t1xbet 카지노 1xbet 카지노alth of people t1xbet 카지노 world over by developing innovative products based on t1xbet 카지노 corporate philosophy of "Otsuka-people creating new products for better 1xbet 카지노alth worldwide".

• *1 Journal of Japan Society for Menopause and Women's 1xbet 카지노alth, 20: 313-332, 2012
• *2 Nutraceuticals：nutrition＋pharmaceuticals
  Products developed based on scientific evidence that contribute to t1xbet 카지노 maintenance and promotion of everyday 1xbet 카지노alth.

Product Information

Product Site　http://equelle.jp/